As noted in last month's eNewsletter, China has been working on significant revisions to its medical device laws. On March 31, 2014, the Chinese government released amendments to the "Regulations on the Supervision and Administration of Medical Devices." Read More
The Indian government has allowed pharmaceutical companies to raise the maximum retail prices (MRPs) for drugs. Pursuant to the Drug Price Control Order (DPCO) 2013, essential medicine prices are capped at the average increase of all drugs in a certain segment that... Read More
On March 24, 2014, the China Food and Drug Administration (CFDA) announced a 5 month national campaign to reinforce medical device product standards. The campaign will focus on the manufacture, sale and usage of Class 2 and Class 3 devices. Growing at... Read More
In April 2013, PBM noted in a newsbrief that India's Central Government Health Scheme (CGHS) had reduced its reimbursement prices for cardio products -- such as drug-eluting stents (DES) -- by up to 60%. Stents that had been approved by the U.S.... Read More
Although the value of global private equity deals in the healthcare sector fell by more than half over 2013, investment in Asia is booming. Between 2011 and 2013, the volume of investment in Asia-Pacific healthcare grew 130%, with India and China leading... Read More
On March 31, 2014, the Chinese government released a revised version of the "Regulations on the Supervision and Administration of Medical Devices." These regulations were approved by the State Council on February 13, 2014 and will officially go into effect June 1,... Read More
Malaysia's pharmaceutical market is valued at over $3 billion and has a double-digit annual growth rate. Thanks to an increasingly affluent and expanding middle class, an aging population, urbanization and higher quality healthcare and medicines, Malaysians spent about $400 per person on... Read More
The pharmaceutical market in Thailand had a 2013 value of more than $4.5 billion, almost the same size as the Taiwan market. Already the second largest in Southeast Asia (behind Indonesia). the Thai drug market is projected to double by 2020. Read More
A country of 15 million people, Cambodia’s 2013 GDP was about $15.5 billion with growth around 7%. As the Cambodian economy develops, healthcare spending has been expanding throughout the country. Though still smaller and more difficult to do business in than many... Read More
On February 13, 2014, the Chinese State Council approved a revised Medical Devices Regulations, which was first adopted in 2000. The revision of the bill started in 2006, with a draft submitted to the State Council in early 2008. The updated regulation... Read More